ConjuChem Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • IPO

  • Latest Deal Amount
  • $16.5M

ConjuChem General Information

Description

ConjuChem Biotechnologies Inc is a Canada based biotechnology company. It is primarily engaged in the business of creating novel, next-generation medicines using long-acting therapeutic peptides. The company's compounds are bio-conjugation platforms called Drug Affinity Complex (DAC) and Preformed Conjugate-Drug Affinity Complex (PC-DAC). When applied to a given peptide, DAC and PC- DAC can create new drugs with similar therapeutic activities but with longer duration of activity and improved safety profiles. The group's pipeline includes CJC-1134-PC for the treatment of diabetes, PC-DAC Insulin for the treatment of diabetes and DAC HIV for treating HIV.

Contact Information

Formerly Known As
ConjuChem Biotechnologies, RedCell Canada
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 225 President-Kennedy Avenue
  • Suite 3950
  • Montreal, Quebec H2X 3Y8
  • Canada
+1 (514)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 225 President-Kennedy Avenue
  • Suite 3950
  • Montreal, Quebec H2X 3Y8
  • Canada
+1 (514)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ConjuChem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. IPO 26-Feb-2001 $16.5M Completed Generating Revenue
3. Early Stage VC 12-Jan-2000 Completed Product Development
2. Early Stage VC (Series B) 09-Aug-1999 $8.48M $11.6M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Apr-1998 $3.11M $3.11M Completed Product Development
To view ConjuChem’s complete valuation and funding history, request access »

ConjuChem Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
ConjuChem Biotechnologies Inc is a Canada based biotechnology company. It is primarily engaged in the business of creati
Biotechnology
Montreal, Canada
44 As of 2009

Somerville, MA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ConjuChem Competitors (12)

One of ConjuChem’s 12 competitors is Genetix Biotherapeutics, a Private Equity-Backed company based in Somerville, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Lite Strategy Corporation San Diego, CA
RedHill Biopharma Formerly VC-backed Raleigh, NC
Quantum BioPharma Corporation Toronto, Canada
Repare Therapeutics Formerly VC-backed Saint-Laurent, Canada
You’re viewing 5 of 12 competitors. Get the full list »

ConjuChem Patents

ConjuChem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12551541-B2 Albumin bound macromolecule tri-agonist activating glp 1/gip/glucagon receptors and methods therefor Active 26-Jun-2023
US-20240424072-A1 Albumin bound macromolecule tri-agonist activating glp 1/gip/glucagon receptors and methods therefor Active 26-Jun-2023
US-20260183374-A1 Albumin bound macromolecule tri-agonist activating glp 1/gip/glucagon receptors and methods therefor Pending 26-Jun-2023
US-20240425557-A1 Albumin bound macromolecule tri-agonist activating glp-1/gip/glucagon receptors Active 26-Jun-2023
WO-2011109784-A1 Formulation of insulinotropic peptide conjugates Inactive 05-Mar-2010 C07K14/65
To view ConjuChem’s complete patent history, request access »

ConjuChem Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ConjuChem Investments (1)

ConjuChem’s most recent deal was a Joint Venture with Changshan Kaijiejian Biopharmaceutical R&D (Hebei). The deal was made on 25-Dec-2012.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Changshan Kaijiejian Biopharmaceutical R&D (Hebei) 25-Dec-2012 Joint Venture Discovery Tools (Healthcare)
To view ConjuChem’s complete investments history, request access »

ConjuChem FAQs

  • When was ConjuChem founded?

    ConjuChem was founded in 1997.

  • Where is ConjuChem headquartered?

    ConjuChem is headquartered in Montreal, Canada.

  • What is the size of ConjuChem?

    ConjuChem has 44 total employees.

  • What industry is ConjuChem in?

    ConjuChem’s primary industry is Biotechnology.

  • Is ConjuChem a private or public company?

    ConjuChem is a Private company.

  • What is ConjuChem’s current revenue?

    The current revenue for ConjuChem is .

  • How much funding has ConjuChem raised over time?

    ConjuChem has raised $30.7M.

  • Who are ConjuChem’s competitors?

    Genetix Biotherapeutics, Lite Strategy, RedHill Biopharma, Quantum BioPharma, and Repare Therapeutics are some of the 12 competitors of ConjuChem.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process